Journal
MOLECULAR CELL
Volume 74, Issue 3, Pages 436-+Publisher
CELL PRESS
DOI: 10.1016/j.molcel.2019.02.030
Keywords
-
Categories
Funding
- EU FP7 infrastructure grant BIOSTRUCT-X [283570]
- Medical Research Council [U105192732]
- European Research Council [724804]
- Lister Institute for Preventive Medicine
- Jesus College, Cambridge
- European Research Council (ERC) [724804] Funding Source: European Research Council (ERC)
- MRC [MC_U105192732] Funding Source: UKRI
Ask authors/readers for more resources
The evolutionarily related deubiquitinating enzymes (DUBs) USP25 and USP28 comprise an identical overall domain architecture but are functionally non-redundant: USP28 stabilizes c-MYC and other nuclear proteins, and USP25 regulates inflammatory TRAF signaling. We here compare molecular features of USP25 and USP28. Active enzymes form distinctively shaped dimers, with a dimerizing insertion spatially separating independently active catalytic domains. In USP25, but not USP28, two dimers can form an autoinhibited tetramer, where a USP25-specific, conserved insertion sequence blocks ubiquitin binding. In full-length enzymes, a C-terminal domain with a previously unknown fold has no impact on oligomerization, but N-terminal regions affect the dimer-tetramer equilibrium in vitro. We confirm oligomeric states of USP25 and USP28 in cells and show that modulating oligomerization affects substrate stabilization in accordance with in vitro activity data. Our work highlights how regions outside of the catalytic domain enable a conceptually intriguing interplay of DUB oligomerization and activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available